1 serum , urine and pharmacologic effect ( prolongation of the qt interval ) kinetics of the antiarrhythmic disopyramide have been investigated in eight volunteers after intravenous administration ( 2 mg/kg ) and oral administration ( 300 mg ) of the two commercially available preparations , rythmodan ( roussel laboratories ) and norpace ( searle laboratories ) .
C0003195
antiarrhythmic
C0012702
disopyramide